Prot# CMX001-104/A03: A Multicenter, Randomized, Double-Bind, Placebo-Controlled, Multiple Dose Study of the Safety, Tolerability and Population Pharmacokinectics of CMX001 in Post-Transplant Subjects with BK Virus Viruria